RxDoctor Payments Data

Alison Polston

Family · San Antonio, TXNPI 1780022806

Payments from drug & device makers

$19,778in general payments, 2019–2025

Across 811 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$4K
  • AstraZeneca$4K
  • UCB, Inc.$3K
  • Amgen$2K
  • AbbVie$2K
  • Novartis$1K
  • plus $4K from 29 others

What the payments were for

  • Consulting fees$4,51023%
  • Travel & lodging$7004%
  • Food & beverage$14,40273%
  • Education$1651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,778 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib23$163,393
MounjaroTirzepatide11$11,295
Hydroxychloroquine Sulfate101$3,467
MethotrexateMethotrexate Sodium96$2,401
Gabapentin76$1,998
Pregabalin77$1,858
Cevimeline Hcl12$1,775
Duloxetine Hcl35$1,387
Tramadol Hcl132$1,194
Eszopiclone15$1,174
Celecoxib21$685
Prednisone62$566
Modafinil12$397
Zolpidem Tartrate85$329
Ondansetron OdtOndansetron13$326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,866$163,39323 claims
Lilly USA, LLCMounjaro$726$11,29511 claims
Almatica Pharma LLCSertraline Hcl$23$7411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.

Other family in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →